Learn, Analyse & Invest
only with
only with
+91
Download Orca
Oxygenta Pharmaceutical Ltd.
Oxygenta Pharma
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹2.01 Cr.
| EX-Date | Purpose |
|---|---|
| 30 06 2021 | Audited Results |
| 12 08 2021 | Quarterly Results |
| 15 11 2021 | Quarterly Results |
| 14 02 2022 | Quarterly Results |
| 20 05 2022 | Audited Results |
| 12 08 2022 | Quarterly Results |
| 12 11 2022 | Quarterly Results |
| 14 02 2023 | Quarterly Results |
| 27 02 2023 | Preferential Issue of shares & Increase in Authorised Capital & Inter-alia, to consider and approve: 1. Raising of funds by way of issue of Securities (both equity and warrants) on preferential basis as per the Regulation of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 read with Companies Act, 2013 and rules made thereunder. 2. Conversion of unsecured loan into equity shares through preferential issue as per the Regulation of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 read with Companies Act, 2013 and rules made thereunder. 3. Other corporate/ incidental matters. |
| 30 05 2023 | Audited Results |
| 14 08 2023 | Quarterly Results |
| 14 11 2023 | Quarterly Results |
| 14 02 2024 | Quarterly Results |
| 08 04 2024 | Inter-alia, to consider and approve: 1. Raising of funds by way of issue of Equity Shares on preferential basis as per the Regulation of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 read with Companies Act, 2013 and rules made thereunder. 2. Other corporate/ incidental matters. |
| 14 11 2024 | Quarterly Results |
| 14 02 2025 | Quarterly Results |
| 30 05 2025 | Audited Results |
| 14 08 2025 | Quarterly Results |
| 07 11 2025 | Quarterly Results |
| 04 02 2026 | Quarterly Results |
News
No News data available
